InsidersTradesSigma
대화제약 Stock: price and directors' dealings · South Korea · DART (FSS)
Follow the 대화제약 share price and the full management transaction log of the company, a listed equity based in South Korea. Shares are quoted on KR KR, under the oversight of DART (FSS). Operating in the Health Care sector, 대화제약 has recorded 129 insider filings. Market capitalisation: €163.1bn. The latest transaction was filed on 2 July 2026 (Other). Among the most active insiders: 김수지. The full history is free.
129
Insider Decl.
0
Thresholds
€69,224
11 ops.
Buy Volume
€29,868
19 ops.
Sell Volume
31Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 19,802 of 26,270 companies
34.3
score / 100
Value37
Quality32
FCF yld0.4%
Earn yld1.0%
EV/EBITDA16.8x
ROE3.0%
Gross mgn33%
Net mgn1.2%
Debt/EBITDA6.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 2 July 2026
Declarations129 total
25 of 129 declarations
About 대화제약
대화제약 is a company operating in the healthcare and pharmaceutical sector, listed on the XKRX market. It focuses on the development and distribution of pharmaceutical products.